Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Zimmer Biomet Holdings, Inc. (ZBH) had Revenue of $7.68B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$7.68B
Net Income	$903.80M
Cost of Goods Sold	$2.19B
Gross Profit	$5.49B
Operating Expenses	$6.39B
Operating Income	$1.29B
Non-Operating Income/Expense	$-249.10M
Pre-Tax Income	$1.04B
Normalized Pre-Tax Income	$1.04B
Income after Taxes	$905.20M
Income from Continuous Operations	$905.20M
Consolidated Net Income/Loss	$905.20M
Normalized Income after Taxes	$905.20M
EBIT	$1.29B
EBITDA	$2.28B
Weighted-Average Shares Outstanding (Basic)	203.10M
Weighted-Average Shares Outstanding (Diluted)	203.90M
Earnings per Share (EPS) (Basic)	$4.45
Earnings per Share (EPS) (Diluted)	$4.43
Balance Sheet Financials
Current Assets	$4.67B
Property, Plant, and Equipment	$2.05B
Long-Term Assets	$16.69B
Total Assets	$21.37B
Current Liabilities	$2.45B
Long-Term Debt	$5.34B
Long-Term Liabilities	$6.44B
Total Liabilities	$8.89B
Common Equity	$12.48B
Tangible Shareholders Equity	$-1.07B
Shareholders Equity	$12.48B
Common Shares Outstanding	199.10M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.50B
Cash Flow from Investing Activities	$-888.10M
Cash Flow from Financial Activities	$-484.50M
Beginning Cash	$415.80M
End Cash	$525.50M
Increase/Decrease in Cash	$109.70M
Stock-Based Compensation	$101.00M
Common Stock Dividends Paid	$-196.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.91
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.30
Debt to Equity Ratio	0.50
Gross Margin	71.46%
Operating Margin	16.74%
EBIT Margin	16.74%
EBITDA Margin	29.72%
Pre-Tax Profit Margin	13.50%
Profit Margin	11.77%
Free Cash Flow	$1.06B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.36
Inventory Turnover	0.98
Receiveable Turnover	5.19
Days Sales in Receivables	70.38
Return on Equity	7.26%
Return on Tangible Equity	-84.34%
Return on Assets	4.24%
Return on Investments	5.08%
Book Value Per Share	$62.66
Free Cash Flow per Share	$5.18
Operating Cash Flow per Share	$7.35

Data from Zacks Investment Research, Inc.